Anti-inflammatory activity of silymarin in patients with knee osteoarthritis. A comparative study with piroxicam and meloxicam

吡罗昔康 美洛昔康 医学 骨关节炎 内科学 药理学 白细胞介素 胃肠病学 细胞因子 病理 替代医学
作者
Saad Abdulrahman Hussain,Nizar Abdulateef Jassim,Intesar T. Numan,Ihab I. Al-Khalifa,Talal A. Abdullah
出处
期刊:Saudi Medical Journal [Ministry of Defence and Aviation]
卷期号:30 (1): 98-103 被引量:35
标识
DOI:10.15537/1658-3175.4604
摘要

OBJECTIVE: To evaluate the anti-inflammatory effect of Silymarin in patients with knee osteoarthritis (OA) in comparison with piroxicam and meloxicam. METHODS: A double-blind clinical trial was performed at the Department of Rheumatology, Baghdad Teaching Hospital, Baghdad, Iraq during the period from October 2004 to September 2005, in which 220 patients (79 males and 141 females) with painful knee osteoarthritis were randomized into 5 groups, treated with either silymarin (300 mg/day), piroxicam (20 mg/day), meloxicam (15 mg), or a combination of silymarin with piroxicam or meloxicam. Serum levels of interleukin-1 alpha, interleukin-8, and the complement proteins C3 and C4 were assessed at zero time, and after 8 weeks. RESULTS: Silymarin reduces significantly serum levels of IL-1 alpha and IL-8, C3 and C4 after 8 weeks compared to the pre-treatment levels. Piroxicam showed no significant reduction in IL-1 alpha levels, while IL-8 decreased significantly, compared to pre-treatment value. Meloxicam elevates serum levels of IL-1 alpha significantly, while IL-8 did not significantly change compared to the pre-treatment value. Piroxicam or meloxicam produced slight, non-significant increase in serum levels of complement proteins after the 8-week treatment period. Adjunct use of silymarin with piroxicam results in significant reduction in both cytokines (IL-1 alpha and IL-8), and serum levels of C3 and C4. However, its adjunct use with, meloxicam did not reveal any significant changes in this respect. CONCLUSION: Silymarin reduces the elevated levels of interleukins and complement proteins, when used alone, or in combination with NSAIDs for the treatment of knee OA.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
qaq发布了新的文献求助10
刚刚
1秒前
SciGPT的应助被corleeang采纳,获得10
1秒前
2秒前
2秒前
大个的应助被是个i人采纳,获得10
2秒前
凑狗发布了新的文献求助10
2秒前
2秒前
Metx完成签到,获得积分10
3秒前
若若完成签到 ,获得积分10
3秒前
曾经的盈发布了新的文献求助10
4秒前
耍酷季节的应助被成就自行车采纳,获得30
4秒前
4秒前
4秒前
汉堡包的应助被Lily采纳,获得10
5秒前
5秒前
hahaha625的应助被123SDFG采纳,获得10
5秒前
远方发布了新的文献求助30
6秒前
所所的应助被Liu采纳,获得10
6秒前
博修发布了新的文献求助10
6秒前
6秒前
英俊的冷风完成签到,获得积分10
7秒前
棕棕完成签到,获得积分10
7秒前
白鯨完成签到,获得积分10
7秒前
7秒前
汉堡包的应助被闪电先生采纳,获得10
7秒前
kongbaige发布了新的文献求助10
8秒前
8秒前
9秒前
积极的小伙完成签到,获得积分10
9秒前
朴实如冰完成签到,获得积分10
9秒前
上官若男的应助被corleeang采纳,获得10
9秒前
9秒前
10秒前
海纳斯完成签到,获得积分10
10秒前
曾经的盈完成签到,获得积分10
10秒前
果粒程完成签到,获得积分10
10秒前
七七完成签到,获得积分10
10秒前
一一完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183070
求助须知:如何正确求助?哪些是违规求助? 9572393
关于积分的说明 21824679
捐赠科研通 7779769
什么是DOI,文献DOI怎么找? 3433810
关于科研通互助平台的介绍 2558045
邀请新用户注册赠送积分活动 2480022